Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPERA: Optimizing PSMA Imaging in Low PSA Recurrence Prostate Cancer
NCT07593079Phase 2Not yet recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flotufolastat f 18 in prostate cancer (PCa), sponsored by Washington University School of Medicine. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
flotufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07593079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07593079.